Patents by Inventor Massimo Zollo

Massimo Zollo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HUMAN NEUTRALIZING ANTIGEN SPECIFIC PROTEINS FOR SPIKE-RBD OF SARS-COV-2
    Publication number: 20240166727
    Abstract: The invention concerns antigen specific proteins, in particular antibodies or fragments thereof, specifically binding to RBD domain and interfering in the interaction of Spike protein with ACE2 receptor, said antigen specific proteins having neutralizing activity for infection of SARS-COV2 virus and its derived variants.
    Type: Application
    Filed: March 21, 2022
    Publication date: May 23, 2024
    Applicant: CEINGE BIOTECNOLOGIE AVANZATE SCARL
    Inventors: Claudia De Lorenzo, Nicola Zambrano, Massimo Zollo
  • METHOD FOR DETERMINING ACTIVE SARS-COV-2-INFECTIONS
    Publication number: 20230383369
    Abstract: Method for early determination of an active SARS-CoV2 infection, based on identification of subgenomic regions of the virus, and kits specifically designed for performing it.
    Type: Application
    Filed: December 23, 2021
    Publication date: November 30, 2023
    Applicant: CEINGE BIOTECNOLOGIE AVANZATE S.C. A R.L.
    Inventors: Ettore Domenico Capoluongo, Veronica Ferrucci, Massimo Zollo
  • Use of microrna-199b-5p in medical and diagnostic field
    Patent number: 9017938
    Abstract: This invention concerns the use of MicroRNA-199b-5p in medical and diagnostic fields. Particularly, this invention concerns the use of the miR199b-5p in the anti-cancer therapy and as a histophatological and metastasis marker.
    Type: Grant
    Filed: March 23, 2010
    Date of Patent: April 28, 2015
    Assignee: Advanced Accelerator Applications
    Inventor: Massimo Zollo
  • USE OF MICRORNA-199B-5P IN MEDICAL AND DIAGNOSTIC FIELD
    Publication number: 20120108656
    Abstract: This invention concerns the use of MicroRNA-199b-5p in medical and diagnostic fields. Particularly, this invention concerns the use of the miR199b-5p in the anti-cancer therapy and as a histophatological and metastasis marker.
    Type: Application
    Filed: March 23, 2010
    Publication date: May 3, 2012
    Inventor: Massimo Zollo
  • Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune
    Publication number: 20090118171
    Abstract: The invention relates to the use of enzymatic inhibitors of h-PRUNE and to screening method for the prevention and treatment of the metastases of tumours overexpressing h-PRUNE thereof and to the diagnostic kit for the prognosis of said metastases thereof.
    Type: Application
    Filed: December 10, 2004
    Publication date: May 7, 2009
    Inventor: Massimo Zollo